Viking Therapeutics

Marianne Mancini serves as our Chief Operating Officer. Ms. Mancini has over 30 years of experience in the pharmaceutical and biotechnology industry focusing on the management and oversight of clinical trials from early-stage to late-stage drug development and most recently served as the company’s senior vice president of clinical operations.

Basic Information

Documented Facts

Evidence and Sources

Citation Guidance

Explore Metabolic Diseases profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Viking Therapeutics.

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Marianne Mancini serves as our Chief Operating Officer. Ms. Mancini has over 30 years of experience in the pharmaceutical and biotechnology industry focusing on the management and oversight of clinical trials from early-stage to late-stage drug development and most recently served as the company’s senior vice president of clinical operations.

Available profile information

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.